©The Author(s) 2017.
World J Gastrointest Oncol. Aug 15, 2017; 9(8): 314-318
Published online Aug 15, 2017. doi: 10.4251/wjgo.v9.i8.314
Published online Aug 15, 2017. doi: 10.4251/wjgo.v9.i8.314
Table 1 Demographic and clinical characteristics of patients with pancreatic cancer receiving S-1 treatment
| Number of patients (n = 22) | |
| Age (yr), median (range) | 68 (48-85) |
| Sex | |
| Male | 9 |
| Female | 13 |
| Body mass index (kg/m2) median (range) | 21 (18-27) |
| ECOG PS | |
| 0 | 15 |
| 1 | 5 |
| 2 | 2 |
| Drinking habit | |
| Yes | 6 |
| No | 16 |
| Diabetes mellitus | |
| Yes | 6 |
| No | 16 |
| Disease status | |
| Locally advanced | 14 |
| Metastatic | 8 |
| Liver metastasis | |
| Yes | 5 |
| No | 17 |
| Biliary drainage | |
| Yes | 7 |
| No | 15 |
| Combination with radiotherapy | |
| Yes | 12 |
| No | 10 |
| Alanine transaminase concentration (U/L), median (range) | 21 (8-73) |
- Citation: Tsuji K, Doyama H. S-1 induced hepatic steatosis in patients with pancreatic cancer: Retrospective analysis. World J Gastrointest Oncol 2017; 9(8): 314-318
- URL: https://www.wjgnet.com/1948-5204/full/v9/i8/314.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v9.i8.314